Success Stories: NAILG Secures Swift EB2-NIW Approval for a Chinese PhD Candidate Advancing AI in Drug Development
On May 14th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a PhD Candidate in the Field of Artificial Intelligence for Drug Development (Approval Notice). General Field: Artificial Intelligence for Drug Development Position at the Time of Case Filing: PhD Candidate Country of Origin: China State of Residence at the time of filing:
Read more [...]